Search - tctmd.com

Displaying 1 - 20 of 42

Sort: Relevancy | Date

News Daily News

In ISCHEMIA, Stable CAD Treatment Effect Hinged on MI Definition

Michael O'Riordan

December 11, 2020

News Features

Too Easy to Misconstrue: Is It Time to Ditch Periprocedural MI?

Michael O'Riordan

December 02, 2020

News Conference News

‘Healing’ Stent Noninferior to Permanent-Polymer Device: PIONEER III

Shelley Wood

November 19, 2020

News Conference News AHA 2020

Latest Post-DES Drug Trial Tests Aspirin Monotherapy After 1 Month of DAPT

Shelley Wood

November 15, 2020

News Conference News AHA 2020

Clopidogrel Should Remain Antiplatelet of Choice in Elective PCI: ALPHEUS

Michael O'Riordan

November 14, 2020

News Daily News

Fewer MIs With Prasugrel Than Ticagrelor in STEMI Patients: ISAR-REACT 5

Michael O'Riordan

November 03, 2020

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for October 2020

Shelley Wood

October 30, 2020

News Daily News

Superiority of Ticagrelor Over Clopidogrel in ACS Questioned

Todd Neale

October 29, 2020

News Daily News

Failure to Access Coronaries After TAVR Almost Exclusive to CoreValve Evolut

Michael O'Riordan

October 28, 2020

News Daily News

More Risk of Death—All, Cardiac, and Noncardiac—With PCI Over Surgery: Meta-analysis

Michael O'Riordan

October 23, 2020

News Conference News TCT 2020

Shorter DAPT Succeeds in Xience-Treated Patients at High Bleeding Risk

Caitlin E. Cox

October 15, 2020

News Conference News TCT 2020

Bivalirudin vs Heparin Patient-Level Meta-analysis Stirs an Old Debate

Shelley Wood

October 14, 2020

News Conference News TCT 2020

Ticagrelor Monotherapy Following 3-Month DAPT Cuts Post-PCI Bleeding After STEMI

Todd Neale

October 14, 2020

News Conference News TCT 2020

No Reperfusion Benefit From Crushed Prasugrel Prior to PCI: COMPARE CRUSH

L.A. McKeown

October 14, 2020

News Opinion CV Team Dispatch

October 2020 News Roundup

L.A. McKeown

October 01, 2020

News Daily News

‘Aspirin-Free’ Antiplatelet Strategy Feasible After PCI, Pilot Study Suggests

Michael O'Riordan

September 18, 2020

News Daily News

‘Speaking the Same Language’: New Guidance for Trials of Patients at High Bleeding Risk

Michael O'Riordan

September 16, 2020

News Conference News ESC 2020

More Bleeding, Death With Ticagrelor Over Clopidogrel in Elderly Post-MI Patients: SWEDEHEART

Yael L. Maxwell

September 08, 2020

News Daily News

Analysis Supports Short DAPT Followed by P2Y12 Inhibitor Monotherapy After DES PCI

L.A. McKeown

August 10, 2020

News Daily News

Short DAPT Reduces Bleeding With No Increase in MACE: Meta-analysis

Yael L. Maxwell

June 30, 2020

Advertisement

In ISCHEMIA, Stable CAD Treatment Effect Hinged on MI Definition

Too Easy to Misconstrue: Is It Time to Ditch Periprocedural MI?

‘Healing’ Stent Noninferior to Permanent-Polymer Device: PIONEER III

Latest Post-DES Drug Trial Tests Aspirin Monotherapy After 1 Month of DAPT

Clopidogrel Should Remain Antiplatelet of Choice in Elective PCI: ALPHEUS

Fewer MIs With Prasugrel Than Ticagrelor in STEMI Patients: ISAR-REACT 5

TCTMD’s Top 10 Most Popular Stories for October 2020

Superiority of Ticagrelor Over Clopidogrel in ACS Questioned

Failure to Access Coronaries After TAVR Almost Exclusive to CoreValve Evolut

More Risk of Death—All, Cardiac, and Noncardiac—With PCI Over Surgery: Meta-analysis

Shorter DAPT Succeeds in Xience-Treated Patients at High Bleeding Risk

Bivalirudin vs Heparin Patient-Level Meta-analysis Stirs an Old Debate

Ticagrelor Monotherapy Following 3-Month DAPT Cuts Post-PCI Bleeding After STEMI

No Reperfusion Benefit From Crushed Prasugrel Prior to PCI: COMPARE CRUSH

October 2020 News Roundup

‘Aspirin-Free’ Antiplatelet Strategy Feasible After PCI, Pilot Study Suggests

‘Speaking the Same Language’: New Guidance for Trials of Patients at High Bleeding Risk

More Bleeding, Death With Ticagrelor Over Clopidogrel in Elderly Post-MI Patients: SWEDEHEART

Analysis Supports Short DAPT Followed by P2Y12 Inhibitor Monotherapy After DES PCI

Short DAPT Reduces Bleeding With No Increase in MACE: Meta-analysis

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content